title: Effectiveness of adalimumab for refractory serpiginous choroiditis.
authors.affiliation: Department of Ophthalmology and.
authors.forename: Ana
authors.initials: A
authors.lastname: Chinchurreta Capote
authors.forename: José M
authors.initials: JM
authors.lastname: Requena Jiménez
authors.forename: Mercedes
authors.initials: M
authors.lastname: Lorenzo Soto
authors.forename: Carlos
authors.initials: C
authors.lastname: Romero Gómez
authors.forename: María Dolores
authors.initials: MD
authors.lastname: García de Lucas
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002833:Choroiditis / Q000175:diagnosis / Q000188:drug therapy*; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006801:Humans; D008297:Male; D000080364:Multifocal Choroiditis; D041623:Tomography, Optical Coherence; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab